Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16557433rdf:typepubmed:Citationlld:pubmed
pubmed-article:16557433lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:16557433lifeskim:mentionsumls-concept:C0679729lld:lifeskim
pubmed-article:16557433lifeskim:mentionsumls-concept:C1518578lld:lifeskim
pubmed-article:16557433lifeskim:mentionsumls-concept:C0024623lld:lifeskim
pubmed-article:16557433lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:16557433lifeskim:mentionsumls-concept:C0023413lld:lifeskim
pubmed-article:16557433lifeskim:mentionsumls-concept:C0246415lld:lifeskim
pubmed-article:16557433lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:16557433lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:16557433lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:16557433lifeskim:mentionsumls-concept:C0699967lld:lifeskim
pubmed-article:16557433pubmed:issue1lld:pubmed
pubmed-article:16557433pubmed:dateCreated2006-3-24lld:pubmed
pubmed-article:16557433pubmed:abstractTextWe assessed the efficacy and safety profile of a docetaxel (Taxotere; Sanofi-Aventis, France), fluorouracil (FU), and leucovorin (LV) combination (TFL), as first-line chemotherapy in patients with advanced gastric cancer.lld:pubmed
pubmed-article:16557433pubmed:languageenglld:pubmed
pubmed-article:16557433pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16557433pubmed:citationSubsetIMlld:pubmed
pubmed-article:16557433pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16557433pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16557433pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16557433pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16557433pubmed:statusMEDLINElld:pubmed
pubmed-article:16557433pubmed:issn1436-3291lld:pubmed
pubmed-article:16557433pubmed:authorpubmed-author:KalofonosHara...lld:pubmed
pubmed-article:16557433pubmed:authorpubmed-author:FountzilasGeo...lld:pubmed
pubmed-article:16557433pubmed:authorpubmed-author:SkarlosDimost...lld:pubmed
pubmed-article:16557433pubmed:authorpubmed-author:BafaloukosDim...lld:pubmed
pubmed-article:16557433pubmed:authorpubmed-author:KosmidisParis...lld:pubmed
pubmed-article:16557433pubmed:authorpubmed-author:TsavdaridisDi...lld:pubmed
pubmed-article:16557433pubmed:authorpubmed-author:PapakostasPav...lld:pubmed
pubmed-article:16557433pubmed:authorpubmed-author:BamiasAristot...lld:pubmed
pubmed-article:16557433pubmed:authorpubmed-author:SakantamisAth...lld:pubmed
pubmed-article:16557433pubmed:authorpubmed-author:JaninisDimitr...lld:pubmed
pubmed-article:16557433pubmed:authorpubmed-author:XirosNikosNlld:pubmed
pubmed-article:16557433pubmed:issnTypePrintlld:pubmed
pubmed-article:16557433pubmed:volume9lld:pubmed
pubmed-article:16557433pubmed:ownerNLMlld:pubmed
pubmed-article:16557433pubmed:authorsCompleteYlld:pubmed
pubmed-article:16557433pubmed:pagination26-31lld:pubmed
pubmed-article:16557433pubmed:dateRevised2007-1-8lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:meshHeadingpubmed-meshheading:16557433...lld:pubmed
pubmed-article:16557433pubmed:year2006lld:pubmed
pubmed-article:16557433pubmed:articleTitleCombination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study.lld:pubmed
pubmed-article:16557433pubmed:affiliationOncology Department, Hippokration General Hospital, 108, Vas.Sofias Avenue, Athens, Greece.lld:pubmed
pubmed-article:16557433pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16557433pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed